Bill DetailsOfficial information provided by the Congressional Research Service. Learn more or make a suggestion.
The Congressional Research Service writes summaries for most legislation. These summaries are listed here. Causes will update some legislation with a revised summary, title or other key elements.
Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017
A bill to amend title XI of the Social Security Act to require drug manufacturers to publicly justify unnecessary price increases.
Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 This bill amends title XI (General Provisions) of the Social Security Act to require manufacturers of drugs with specified percentage increases in their wholesale costs to submit to the Centers for Medicare & Medicaid Services (CMS) written justification for certain increases in drug prices. The CMS shall publish each submission, together with an easily understandable summary, on its website. Certain proprietary information may be excluded from publication, as specified by the bill. A manufacturer that does not comply with the bill's requirements shall be subject to civil monetary penalties.
- Not enactedThe President has not signed this bill
- The house has not voted
- The senate has not voted
Committee on FinanceIntroducedJune 13th, 2017
- senate Committees